✦ LIBER ✦

Nical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial

✍ Scribed by Paul F. Schellhammer; Roohollah Sharifi; Norman L. Block; Mark S. Soloway; Peter M. Venner; A. Lynn Patterson; Michael F. Sarosdy; Nicholas J. Vogelzang; Julie Jones Schellenger; Geert J.C.M. Kolvenbag

Book ID: 119486928
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 825 KB
Volume: 50
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(97)00279-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined androgen blockade with bicaluta

Combined androgen blockade with bicalutamide for advanced prostate cancer : Long-Term Follow-Up of a Phase 3, Double-Blind, Randomized Study for Survival

✍ Hideyuki Akaza; Shiro Hinotsu; Michiyuki Usami; Yoichi Arai; Hiroshi Kanetake; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB

Maximal androgen blockade for patients w

Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy

✍ Paul Schellhammer; Roohollah Sharifi; Norman Block; Mark Soloway; Peter Venner; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 840 KB

Evaluation of quality of life in patient

Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study

✍ Yoichi Arai; Hideyuki Akaza; Takashi Deguchi; Masato Fujisawa; Mikio Hayashi; Yo 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 258 KB

Long-term efficacy and safety of zoledro

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma : A randomized, double-blind, multicenter, comparative trial

✍ Lee S. Rosen; David Gordon; Mary Kaminski; Anthony Howell; Andrew Belch; John Ma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Abstract ## BACKGROUND The goal of the current study was to compare the long‐term (25‐month) safety and efficacy of zoledronic acid with pamidronate in patients with bone lesions secondary to advanced breast carcinoma or multiple myeloma. ## METHODS Patients (__n__ = 1648) were randomized to

Combined androgen blockade may have long

Combined androgen blockade may have long term survival benefits over monotherapy, but may increase adverse effects and reduce quality of life in advanced prostate cancer: Abstracted from: Samson DJ, Seidenfeld J, Schmitt B et al. Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer 2002; 95:361–376.

✍ H Akaza 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 38 KB